Utah Admin. Code R414-60B-6 - P& T Committee Responsibilities and Functions
(1) The P& T Committee functions as a
professional and technical advisory board to DMHF in the formulation of a
PDL.
(2) P& T Committee
recommendations must:
(a) represent the
majority vote at meetings in which a majority of voting members are present;
and
(b) include votes by at least
one committee member from the group identified in Subsection
R414-60B-5(3)
and one member from the group identified in Subsection
R414-60B-5(4)
(3) The P& T
Committee manager shall schedule meetings, set agendas, provide meeting
materials, keep minutes, record committee business, notify the Director when
vacancies occur, provide meeting notices, and coordinate functions between the
committee and DMHF.
(4) Notice for
a P& T Committee meeting shall be given in accordance with applicable
law.
(5) The P& T Committee
chairperson shall conduct all meetings. The P& T Committee manager shall
conduct meetings if the chairperson is not present.
(6) P& T Committee meetings shall occur
at least quarterly.
(7) P& T
Committee meetings shall be open to the public except when meeting in executive
session.
(8) The committee shall:
(a) review drug classes and make
recommendations to DMHF for PDL implementation;
(b) review new drugs, new drug classes or
both, to make recommendations to DMHF for PDL implementation;
(c) review drugs or drug classes as DMHF
assigns or requests;
(d) review
drugs within a therapeutic class and make a recommendation to DMHF for the
preferred drug or drugs within the therapeutic class; and
(e) review evidence based criteria and drug
information.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
(1) The P& T Committee functions as a professional and technical advisory board to DMHF in the formulation of a PDL.
(2) P& T Committee recommendations must:
(a) represent the majority vote at meetings in which a majority of voting members are present; and
(b) include votes by at least one committee member from the group identified in Subsection R414-60B-5(3) and one member from the group identified in Subsection R414-60B-5(4)
(3) The P& T Committee manager shall schedule meetings, set agendas, provide meeting materials, keep minutes, record committee business, notify the Director when vacancies occur, provide meeting notices, and coordinate functions between the committee and DMHF.
(4) Notice for a P& T Committee meeting shall be given in accordance with applicable law.
(5) The P& T Committee chairperson shall conduct all meetings. The P& T Committee manager shall conduct meetings if the chairperson is not present.
(6) P& T Committee meetings shall occur at least quarterly.
(7) P& T Committee meetings shall be open to the public except when meeting in executive session.
(8) The committee shall:
(a) review drug classes and make recommendations to DMHF for PDL implementation;
(b) review new drugs, new drug classes or both, to make recommendations to DMHF for PDL implementation;
(c) review drugs or drug classes as DMHF assigns or requests;
(d) review drugs within a therapeutic class and make a recommendation to DMHF for the preferred drug or drugs within the therapeutic class; and
(e) review evidence based criteria and drug information.